Finished Pharmaceutical Product
Detailed information related to qualitative and quantitative characteristics of the
finished product should be provided by SU to RU. The information includes:
i. Qualitative and quantitative composition
vii. Safety and handling details.
Information on Process (Processing)
History of process and other information should be provided to RU by SU. This is to
enable RU to perform any further development or optimization of the process after
the transfer of technology. This section includes information on:
iii. Full-scale development act
iv. The history of change and reasons for the change
v. Problem’s investigation and respective outcomes.
SU should provide RU with any information regarding health, safety and
environmental issues. This information is associated with:
ii. Manufacturing process’s implications like the need for growing, etc
The SU should provide RU information on current processing and testing. This
section includes information regarding:
i. The requirement of facility and equipment
iv. Storage requirements for FP, API, and excipients
v. Manufacturing steps description including flowcharts, narrative maps, master
vi. Analytical method description identification and justification of control strategy
a. Critical performance aspects of specific dosage forms
d. Standard process control charts
viii. Product quality reviews and details
xi. Environmental rules and protocols to be followed
Responsibilities of RU: RU should identify if there are any differences in the
No comments:
Post a Comment
اكتب تعليق حول الموضوع